Page 7 of pharma

gem, government emarketplace, gem portal, public procurement, commerce minister, medical device manufacturers, Association of Indian Manufacturers of Medical Devices, MRI, X-Ray, ultrasounds, etc; third, dental products includes dentures, braces, etc; fourth, orthopaedics & prosthetics include knee implants, artificial joints; and fifth, patient aids include hearing aids and pacemakers

Over 300 medical device manufacturers to sell goods directly to govt via GeM portal

According to the marketplace, the onboarding will create direct market linkages between manufacturers of medical devices including, consumables, disposables, equipment,…

January 12, 2024 16:50 IST

India records 841 new Covid cases

Three new fatalities due to Covid– one each from Kerala, Karnataka and Bihar — have been reported in a span…

December 31, 2023 11:57 IST

USFDA, Intas Pharma, Ahmedabad, Quality Assurance, pharma, latest news, top news,

USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant

A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations.

December 10, 2023 11:18 IST

Zydus ties up with Guardant Health to promote cancer tests across India, Nepal

The tests to be promoted include the Guardant360 and Guardant360 TissueNext tests for comprehensive genomic profiling and the Guardant360 Response…

November 2, 2023 12:32 IST

Zydus Lifesciences. healthcare sector, Q2FY24 results, profit, revenue, EBITDA, India formulations, sales

Granules India-NIPER Centre for Innovative & Sustainable Pharma

The centre will focus on crucial areas such as exploring plant-based excipients, advancements in polymer-free pharmaceutical formulations, innovative methods in…

October 14, 2023 17:53 IST

A generic problem: Asymmetric information in the pharma space impairs informed choice, leading to healthcare costs being unnecessarily jacked up

There are lists of the world’s most popular or valued brands

October 12, 2023 06:00 IST

AstraZeneca gets CDSCO approval for preventive therapy for respiratory syncytial virus

The company has received the approval for Palivizumab injection in single-dose vials administered through intramuscular route, it said in a…

September 30, 2023 21:30 IST

pharma sector, pharmaceutical, growth, domestic sales, exports, regulated markets, US generics market, input costs, supply chain, capex plans, export revenues, domestic revenue, revenue growth, manufacturers

Pharma sector Q1 review: Growth led by US market, gRevlimid sales; India growth slips on price cuts, muted volumes

“Growth in domestic pharmaceutical revenues of all the major companies will be moderate. Lower RM prices and easing US generic…

August 28, 2023 07:20 IST

Aurobindo Pharma, HIV drugs, USFDA approval, DGCI, healthcare news, pharma news,

What is attracting private equity funds to Indian pharma?

While a company like Cipla finds it speculative (and not quite worthy of a comment) others like Glenmark proffer specific…

Updated: August 12, 2023 23:57 IST

Cipla stock jumps 9% today on strong Q1 results; should you buy, sell or hold Cipla shares? Check target price

Cipla stock jumped today on solid Q1 performance. Nuvama and Choice have recommended ‘Buy’ and ‘Add’ ratings on the stock,…

July 27, 2023 10:23 IST

healthcare revolution, health news, pharma news,

Revenue of top domestic pharmaceutical firms to grow by 7-9 per cent in FY24: Icra

The growth will be supported by an 8-10 per cent expansion in the domestic market and a 6-8 per cent…

Updated: July 26, 2023 09:18 IST

Dr Reddy’s to enhance presence in emerging segments like nutraceuticals, gene therapy

In its Annual Report for 2022-23, the Hyderabad-based drug major informed the shareholders that it also intends to follow a…

Updated: July 11, 2023 15:24 IST

PharmEasy’s latest fundraise may see steep valuation drop

The holding company is believed to be in advanced stages of talks with Manipal Group for the fund raise.

July 6, 2023 05:45 IST

Lupin stock rating ‘Accumulate’: 13% upside seen on gSpiriva launch, US market gains; check target price

Elara Capital has set a target price of Rs 992 on Lupin stock, which is an upside of 13%, with…

Updated: June 22, 2023 17:07 IST

Drugs, cough syrup, Mansukh Mandaviya, medicines, Global Pharma Healthcare, India

Zero tolerance on spurious medicines, 71 firms issued notices: Mansukh Mandaviya on cough syrup row

In an exclusive interview with PTI video, the minister also said an extensive risk-based analysis is done continuously to ensure…

June 20, 2023 15:41 IST

Alkem Laboratories, ophthalmology market, healthcare news, pharma news,

Jagat Pharma gets WHO certification for eye drops

“Jagat Pharma has successfully conducted clinical trials on Isotine Plus eye drops in patients suffering from immature cataract and other…

May 27, 2023 03:45 IST

Sleep disorders, Sleep apnea, caffeine, healthcare news, pharma news,

This drug works better than caffeine in keeping daytime sleepiness at bay; Here are the details

It is noteworthy that this is the first time that these drugs have been compared against each other in this…

May 25, 2023 15:44 IST

cough syrup, cameroon cough syrup, cameroon deaths, reimann labs, healthcare news,

Now cough syrups in India to undergo mandatory tests before export

However, it is still not clear whether testing would be required for cough syrups sold in the domestic market.

May 23, 2023 13:17 IST

Related News

Income Tax Return Deadline Extension 2025 Live: Latest updates on last date, penalties and refund status

Income Tax Return Deadline Extension 2025 LIVE: Govt extended ITR filing due date in May, yet 5.3 crore returns filed so far

A man turned to LinkedIn and Reddit to expose the “unethical practices” and unwarranted insults he faced during his time at the company. In response, the company has demanded that he delete the LinkedIn post, which it deemed defamatory, within 24 hours or face legal action.

‘Delete LinkedIn post or face notice’: Employee says ex-company threatened him for calling out ‘unethical practices’

Infosys approves Rs 18,000 crore buyback at 19% premium to current price

nitin gadkari, nitin gadkari news, nitin gadkari row, politician, fool people, nitin gadkari remark

Ethanol blending to cross 20%, says Gadkari, Diesel–Isobutanol mix to increase too

The trillion-rupee charge: 5 stocks wiring India’s battery revolution

HIRE Act 2025: Why proposed US law is worrying IT sector

World News29 min ago

Senator Bernie Moreno has introduced the HIRE Act 2025 to discourage US companies from outsourcing jobs by imposing a 25% tax on payments to foreign workers and prohibiting outsourcing deductions. This could affect service exporters like India, but may also violate a WTO agreement. The Act reflects President Trump’s protectionist stance but may not pass.

View all shorts